Healthy, no Evidence of Disease Clinical Trial
Official title:
Phase I Single Dose Safety and Pharmacokinetic Study of a New Formulation of Bowman Birk Inhibitor Concentrate, Delivered as an Orange Juice Suspension to Healthy Male Volunteers Between 18 and 65 Years of Age
This randomized phase I trial is studying the side effects and best dose of Bowman-Birk inhibitor concentrate in healthy men. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of Bowman-Birk inhibitor concentrate may prevent cancer.
OBJECTIVES:
I. Assess the toxicity of single-dose Bowman-Birk Inhibitor Concentrate (BBIC) when
administered as a suspension in orange juice in healthy male participants.
II. Determine the appropriate dose range and doses to be used in a subsequent phase I
multiple-dose BBIC study that will be based upon the data gathered from this phase I
single-dose study.
III. Characterize the pharmacokinetics of single-dose BBIC.
OUTLINE: This is a dose-escalation study of Bowman-Birk Inhibitor Concentrate (BBIC).
Participants are sequentially assigned to 1 of 4 dose level cohorts. One participant in each
dose level cohort is randomized to receive placebo or BBIC.
Participants receive a single dose of oral BBIC or placebo, as an orange juice suspension,
immediately followed by consumption of a defined low-fat breakfast. Participants continue to
consume a low-fat diet for the next 48 hours and then resume their normal diet.
Participants undergo blood and urine sample collection periodically for pharmacokinetic
studies. Samples are analyzed by a sandwich enzyme-linked immunosorbent assay to measure
concentrations of BBIC and its metabolites in serum and urine.
After completion of study treatment, participants are followed once weekly for 4 weeks.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01950403 -
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT01336387 -
Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT01561989 -
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
|
N/A | |
| Completed |
NCT01140646 -
Evaluation of SAMe for Hot Flashes
|
Phase 2 | |
| Completed |
NCT00892515 -
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer
|
N/A | |
| Completed |
NCT00450957 -
Lycopene in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT00365209 -
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
|
Phase 2 | |
| Recruiting |
NCT04445532 -
Hepatobiliary Tumors Tissue Samples Acquisition
|
||
| Completed |
NCT02100254 -
Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities
|
N/A | |
| Completed |
NCT02129517 -
Web-Based Tailored Educational Program in Improving Nurse Communication With Patients About Clinical Trials
|
N/A | |
| Terminated |
NCT01755208 -
Light-Scattering Spectroscopy for Detection of Breast Cancer
|
N/A | |
| Completed |
NCT00392652 -
Diindolylmethane in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00499460 -
Effects of Garlic Supplements on Opioids in Healthy Volunteers
|
Phase 4 | |
| Completed |
NCT01077453 -
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
|
Phase 1 | |
| Completed |
NCT00478309 -
Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants
|
N/A | |
| Completed |
NCT01370889 -
Resveratrol in Postmenopausal Women With High Body Mass Index
|
Phase 1 | |
| Completed |
NCT00896207 -
Studying Different Formulations of SR13668 in Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT02154984 -
Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants
|
N/A | |
| Completed |
NCT00489372 -
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
|
Phase 1 | |
| Completed |
NCT00513916 -
Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women
|
Phase 3 |